Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?

The recent outbreak of coronavirus disease 2019 (COVID-19) has gained considerable attention worldwide due to its increased potential to spread and infect the general population. COVID-19 primarily targets the human respiratory epithelium but also has neuro-invasive potential. Indeed, neuropsychiatr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neuroimmune pharmacology 2021-06, Vol.16 (2), p.213-218
Hauptverfasser:	Chaves Filho, Adriano José Maia, Gonçalves, Franciane, Mottin, Melina, Andrade, Carolina Horta, Fonseca, Silvia Nunes Szente, Macedo, Danielle S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - administration & dosage Antiviral Agents - administration & dosage Biomedical and Life Sciences Biomedicine Cell Biology Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 Drug Treatment Drug Repositioning - methods Humans Immunology Inflammation Mediators - antagonists & inhibitors Inflammation Mediators - immunology Letter to the Editor Mental Disorders - drug therapy Mental Disorders - epidemiology Mental Disorders - immunology Nervous System Diseases - drug therapy Nervous System Diseases - epidemiology Nervous System Diseases - immunology Neurosciences Pharmacology/Toxicology Severe acute respiratory syndrome coronavirus 2 Tetracyclines - administration & dosage Viral infections Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!